Shalabh Gupta serves as the Founder, Chairman, and CEO of Unicycive Therapeutics. He established and has led the company since 2016, successfully taking it public on Nasdaq in 2021. He brings over a decade of leadership experience to his role.
As a physician and entrepreneur, Gupta leverages his expertise in business development, start-ups, and venture capital to drive innovative solutions in healthcare.